Table of Contents
ISRN Obstetrics and Gynecology
Volume 2011, Article ID 453190, 5 pages
http://dx.doi.org/10.5402/2011/453190
Clinical Study

A Profile of Cases of Gestational Trophoblastic Neoplasia at a Large Tertiary Centre in Dubai

Department of Obstetrics and Gynaecology, Al Wasl Hospital, P.O. Box 9115, Dubai, United Arab Emirates

Received 20 April 2011; Accepted 25 May 2011

Academic Editors: J. A. Hyett and Z. M. Lei

Copyright © 2011 Tasneem H. Rangwala and Faiza Badawi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Y. Tse, K. K. L. Chan, K. F. Tam, and H. Y. S. Ngan, “Gestational trophoblastic disease,” Obstetrics, Gynecology and Reproductive Medicine, vol. 19, no. 4, pp. 89–91, 2009. View at Google Scholar
  2. P. savage, “Molar pregnancy,” The obstetrician and Gynecologist, vol. 10, pp. 3–8, 2008. View at Google Scholar
  3. N. J. Sebire, R. A. Fisher, M. Foskett, H. Rees, M. J. Seckl, and E. S. Newlands, “Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy,” British Journal of Obstetrics and Gynaecology, vol. 110, no. 1, pp. 22–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Royal College of Obstetricians and gynaecologists, “The management of Gestational Trophoblastic disease,” RCOG Green Top Guideline NO. 38, 2009.
  5. F. Flam, F. Petterson, and V. Lundstrom, “Medical induction prior to surgical evacuation of Hydatidiform mole. Is there a greater risk of persistent gestational trophoblastic disease?” European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 42, pp. 57–60, 1991. View at Google Scholar
  6. M. Stone and K. D. Bagshawe, “An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy,” British Journal of Obstetrics and Gynaecology, vol. 86, no. 10, pp. 782–792, 1979. View at Google Scholar
  7. M. Pezeshki, B. W. Hancock, P. Silcocks et al., “The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease,” Gynecologic Oncology, vol. 95, no. 3, pp. 423–429, 2004. View at Publisher · View at Google Scholar · View at PubMed
  8. N. Pisal, J. Tidy, and B. Hancock, “Gestational trophoblastic disease: is intensive follow up essential in all women?” British Journal of Obstetrics and Gynaecology, vol. 111, no. 12, pp. 1449–1451, 2004. View at Publisher · View at Google Scholar
  9. N. J. Sebire, M. Foskett, D. Short et al., “Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit,” British Journal of Obstetrics and Gynaecology, vol. 114, no. 6, pp. 760–762, 2007. View at Publisher · View at Google Scholar · View at PubMed